NovoCure Ltd (NVCR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 70M 140M 210M Q3 '14: 4.4M Q4 '14: 3.8M Q1 '15: 5.2M Q2 '15: 6.5M Q3 '15: 9M Q4 '15: 12.4M Q1 '16: 13.1M Q2 '16: 17.9M Q3 '16: 21.7M Q4 '16: 30.2M Q1 '17: 34.9M Q2 '17: 38.4M Q3 '17: 50.1M Q4 '17: 53.7M Q1 '18: 52.1M Q2 '18: 61.5M Q3 '18: 64.8M Q4 '18: 69.7M Q1 '19: 73.3M Q2 '19: 86.7M Q3 '19: 92.1M Q4 '19: 99.2M Q1 '20: 101.8M Q2 '20: 115.9M Q3 '20: 132.7M Q4 '20: 144M Q1 '21: 134.7M Q2 '21: 133.5M Q3 '21: 133.6M Q4 '21: 133.2M Q1 '22: 137.5M Q2 '22: 140.9M Q3 '22: 131M Q4 '22: 128.4M Q1 '23: 122.2M Q2 '23: 126.1M Q3 '23: 127.3M Q4 '23: 133.8M Q1 '24: 138.5M Q2 '24: 150.4M Q3 '24: 155.1M Q4 '24: 161.3M Q1 '25: 155M Q2 '25: 158.8M Q3 '25: 167.2M Q4 '25: 174.3M Q1 '26: 174.1M Q2 '26: 183.6M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Gross Profit Quarterly

0 50M 100M 150M Q3 '14: 1.8M Q4 '14: 1.2M Q1 '15: 1.3M Q2 '15: 1.8M Q3 '15: 3.3M Q4 '15: 6.1M Q1 '16: 5.1M Q2 '16: 1.7M Q3 '16: 10.6M Q4 '16: 19.3M Q1 '17: 23.2M Q2 '17: 25.2M Q3 '17: 35M Q4 '17: 38M Q1 '18: 33.9M Q2 '18: 41.7M Q3 '18: 45.8M Q4 '18: 46.6M Q1 '19: 53.5M Q2 '19: 65.6M Q3 '19: 69.2M Q4 '19: 74.4M Q1 '20: 77.3M Q2 '20: 90.5M Q3 '20: 104.3M Q4 '20: 115.8M Q1 '21: 108.3M Q2 '21: 104.9M Q3 '21: 103.4M Q4 '21: 103.5M Q1 '22: 109.8M Q2 '22: 112.4M Q3 '22: 101.2M Q4 '22: 99.5M Q1 '23: 92.6M Q2 '23: 92M Q3 '23: 95.2M Q4 '23: 101.2M Q1 '24: 104.8M Q2 '24: 115.7M Q3 '24: 119.7M Q4 '24: 127.8M Q1 '25: 116.5M Q2 '25: 117.3M Q3 '25: 122.5M Q4 '25: 132.2M Q1 '26: 135.1M Q2 '26: 142.5M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '14: -17.9M Q4 '14: -23M Q1 '15: -21.9M Q2 '15: -27.2M Q3 '15: -24.2M Q4 '15: -30.6M Q1 '16: -31.9M Q2 '16: -37.2M Q3 '16: -28.3M Q4 '16: -17.9M Q1 '17: -13.4M Q2 '17: -15.5M Q3 '17: -5.9M Q4 '17: -4.5M Q1 '18: -12.7M Q2 '18: -7.1M Q3 '18: -5.2M Q4 '18: -8.7M Q1 '19: -6.1M Q2 '19: 1.2M Q3 '19: 3.9M Q4 '19: 153K Q1 '20: -3.4M Q2 '20: 6.7M Q3 '20: 15M Q4 '20: 12.1M Q1 '21: -88K Q2 '21: -12.3M Q3 '21: -8.6M Q4 '21: -23.4M Q1 '22: -806K Q2 '22: -21.1M Q3 '22: -24.6M Q4 '22: -43M Q1 '23: -60.2M Q2 '23: -62.7M Q3 '23: -58.2M Q4 '23: -51.7M Q1 '24: -41.5M Q2 '24: -33.6M Q3 '24: -32.1M Q4 '24: -63.3M Q1 '25: -37.9M Q2 '25: -39.5M Q3 '25: -36M Q4 '25: -40.4M Q1 '26: -67.4M Q2 '26: -10.6M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Net Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '14: -18.3M Q4 '14: -22.9M Q1 '15: -23.3M Q2 '15: -29.4M Q3 '15: -26M Q4 '15: -32.9M Q1 '16: -35.4M Q2 '16: -40.6M Q3 '16: -33.6M Q4 '16: -22.2M Q1 '17: -18M Q2 '17: -21.2M Q3 '17: -11.5M Q4 '17: -10.9M Q1 '18: -20.7M Q2 '18: -15.5M Q3 '18: -11.7M Q4 '18: -15.6M Q1 '19: -12.2M Q2 '19: -1.3M Q3 '19: 1.9M Q4 '19: 4.3M Q1 '20: 4M Q2 '20: 1.7M Q3 '20: 9.3M Q4 '20: 4.9M Q1 '21: -4.1M Q2 '21: -14.6M Q3 '21: -13.1M Q4 '21: -26.5M Q1 '22: -4.6M Q2 '22: -24M Q3 '22: -26.6M Q4 '22: -37.3M Q1 '23: -53.1M Q2 '23: -57.4M Q3 '23: -49.5M Q4 '23: -47.1M Q1 '24: -38.8M Q2 '24: -33.4M Q3 '24: -30.6M Q4 '24: -65.9M Q1 '25: -34.3M Q2 '25: -40.1M Q3 '25: -37.3M Q4 '25: -24.5M Q1 '26: -71.1M Q2 '26: -15.7M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Cost of Revenue Quarterly

0 20M 40M 60M Q3 '14: 2.6M Q4 '14: 2.6M Q1 '15: 3.9M Q2 '15: 4.8M Q3 '15: 5.7M Q4 '15: 6.3M Q1 '16: 8M Q2 '16: 9.8M Q3 '16: 11.1M Q4 '16: 11M Q1 '17: 11.7M Q2 '17: 13.2M Q3 '17: 15.2M Q4 '17: 15.6M Q1 '18: 18.2M Q2 '18: 19.8M Q3 '18: 18.9M Q4 '18: 23M Q1 '19: 19.8M Q2 '19: 21.1M Q3 '19: 22.9M Q4 '19: 24.8M Q1 '20: 24.5M Q2 '20: 25.5M Q3 '20: 28.4M Q4 '20: 28.1M Q1 '21: 26.4M Q2 '21: 28.6M Q3 '21: 30.2M Q4 '21: 29.7M Q1 '22: 27.7M Q2 '22: 28.5M Q3 '22: 29.7M Q4 '22: 28.9M Q1 '23: 29.6M Q2 '23: 34M Q3 '23: 32.1M Q4 '23: 32.6M Q1 '24: 33.7M Q2 '24: 34.7M Q3 '24: 35.4M Q4 '24: 33.5M Q1 '25: 38.5M Q2 '25: 41.5M Q3 '25: 44.7M Q4 '25: 42.2M Q1 '26: 38.9M Q2 '26: 41.1M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating Cash Flow Quarterly

-40M -20M 0 20M 40M 60M Q4 '14: -17.6M Q1 '15: -28.5M Q2 '15: -23.2M Q3 '15: -22.1M Q4 '15: -26.1M Q1 '16: -31M Q2 '16: -29.4M Q3 '16: -33.5M Q4 '16: -13.7M Q1 '17: -26.9M Q2 '17: -5.9M Q3 '17: 2.5M Q4 '17: -2.9M Q1 '18: -16.8M Q2 '18: -7.5M Q3 '18: 5.6M Q4 '18: 16.8M Q1 '19: -4.3M Q2 '19: 9.1M Q3 '19: 14.9M Q4 '19: 7M Q1 '20: 2M Q2 '20: 12.7M Q3 '20: 31M Q4 '20: 53.5M Q1 '21: 17.8M Q2 '21: 26.2M Q3 '21: 24.4M Q4 '21: 14.4M Q1 '22: -3.7M Q2 '22: 15.8M Q3 '22: 22.4M Q4 '22: -3.7M Q1 '23: -16.7M Q2 '23: -22.7M Q3 '23: -19.3M Q4 '23: -14.6M Q1 '24: -31.6M Q2 '24: -1.7M Q3 '24: 10.4M Q4 '24: -3.5M Q1 '25: -35.7M Q2 '25: -15.9M Q3 '25: 20.6M Q4 '25: -18M Q1 '26: -13.5M Q2 '26: 8.1M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Free Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q4 '14: -18M Q1 '15: -29.1M Q2 '15: -25M Q3 '15: -23.3M Q4 '15: -27.2M Q1 '16: -32M Q2 '16: -31.7M Q3 '16: -35.2M Q4 '16: -14.3M Q1 '17: -27.9M Q2 '17: -6.3M Q3 '17: 2M Q4 '17: -8.3M Q1 '18: -17.6M Q2 '18: -8.3M Q3 '18: 4.3M Q4 '18: 15M Q1 '19: -6.6M Q2 '19: 6.7M Q3 '19: 12.2M Q4 '19: 3.9M Q1 '20: -1.2M Q2 '20: 9.4M Q3 '20: 28.2M Q4 '20: 47.7M Q1 '21: 13.8M Q2 '21: 23.6M Q3 '21: 21.1M Q4 '21: 130K Q1 '22: -8.8M Q2 '22: 11.6M Q3 '22: 16.7M Q4 '22: -10.1M Q1 '23: -22.8M Q2 '23: -29.7M Q3 '23: -26.6M Q4 '23: -21.4M Q1 '24: -43.4M Q2 '24: -13.2M Q3 '24: -307K Q4 '24: -12.4M Q1 '25: -46.3M Q2 '25: -21.4M Q3 '25: 14.9M Q4 '25: -22.9M Q1 '26: -18.7M Q2 '26: 1.2M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q3 '18: 92.9M Q1 '19: 94.8M Q2 '19: 96.4M Q3 '19: 107.6M Q4 '19: 107.9M Q1 '20: 108.1M Q2 '20: 107.6M Q3 '20: 108.6M Q4 '20: 110.6M Q1 '21: 102.6M Q2 '21: 103.5M Q3 '21: 103.7M Q4 '21: 103.9M Q1 '22: 104.2M Q2 '22: 104.6M Q3 '22: 104.9M Q4 '22: 105M Q1 '23: 105.7M Q2 '23: 106.3M Q3 '23: 106.8M Q1 '24: 107.3M Q2 '24: 107.7M Q3 '24: 108.2M Q1 '25: 110.3M Q2 '25: 111.6M Q3 '25: 111.9M Q1 '26: 114.1M Q2 '26: 116M Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q2 '15: -7.37 Q3 '15: -8.01 Q4 '15: -6.61 Q1 '16: -5.26 Q2 '16: -3.38 Q3 '16: -1.68 Q4 '16: -1.55 Q1 '17: -1.34 Q2 '17: -1.10 Q3 '17: -0.84 Q4 '17: -0.70 Q1 '18: -0.72 Q2 '18: -0.65 Q3 '18: -0.65 Q4 '18: -0.70 Q1 '19: -0.60 Q2 '19: -0.44 Q3 '19: -0.29 Q4 '19: -0.08 Q1 '20: 0.09 Q2 '20: 0.12 Q3 '20: 0.19 Q4 '20: 0.19 Q1 '21: 0.11 Q2 '21: -0.05 Q3 '21: -0.27 Q4 '21: -0.56 Q1 '22: -0.56 Q2 '22: -0.65 Q3 '22: -0.77 Q4 '22: -0.88 Q1 '23: -1.34 Q2 '23: -1.65 Q3 '23: -1.86 Q4 '23: -1.94 Q1 '24: -1.80 Q2 '24: -1.57 Q3 '24: -1.39 Q4 '24: -1.56 Q1 '25: -1.51 Q2 '25: -1.56 Q3 '25: -1.61 Q4 '25: -1.22 Q1 '26: -1.53 Q2 '26: -1.30 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.